154 related articles for article (PubMed ID: 24794331)
1. Shrinkage temperature and anti-calcification property of triglycidylamine-crosslinked autologous tissue.
Sato M; Hiramatsu Y; Matsushita S; Sato S; Watanabe Y; Sakakibara Y
J Artif Organs; 2014 Sep; 17(3):265-71. PubMed ID: 24794331
[TBL] [Abstract][Full Text] [Related]
2. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms.
Connolly JM; Alferiev I; Clark-Gruel JN; Eidelman N; Sacks M; Palmatory E; Kronsteiner A; Defelice S; Xu J; Ohri R; Narula N; Vyavahare N; Levy RJ
Am J Pathol; 2005 Jan; 166(1):1-13. PubMed ID: 15631995
[TBL] [Abstract][Full Text] [Related]
3. In vivo biomechanical assessment of triglycidylamine crosslinked pericardium.
Sacks MS; Hamamoto H; Connolly JM; Gorman RC; Gorman JH; Levy RJ
Biomaterials; 2007 Dec; 28(35):5390-8. PubMed ID: 17822757
[TBL] [Abstract][Full Text] [Related]
4. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.
Connolly JM; Bakay MA; Alferiev IS; Gorman RC; Gorman JH; Kruth HS; Ashworth PE; Kutty JK; Schoen FJ; Bianco RW; Levy RJ
Ann Thorac Surg; 2011 Sep; 92(3):858-65. PubMed ID: 21871270
[TBL] [Abstract][Full Text] [Related]
5. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
6. Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation.
Lee WK; Park KD; Kim YH; Suh H; Park JC; Lee JE; Sun K; Baek MJ; Kim HM; Kim SH
J Biomed Mater Res; 2001; 58(1):27-35. PubMed ID: 11152994
[TBL] [Abstract][Full Text] [Related]
7. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
[TBL] [Abstract][Full Text] [Related]
8. Effects of glutaraldehyde concentration and fixation time on material characteristics and calcification of bovine pericardium: implications for the optimal method of fixation of autologous pericardium used for cardiovascular surgery.
Lee C; Lim HG; Lee CH; Kim YJ
Interact Cardiovasc Thorac Surg; 2017 Mar; 24(3):402-406. PubMed ID: 28011740
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.
Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ
Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944
[TBL] [Abstract][Full Text] [Related]
10. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879
[TBL] [Abstract][Full Text] [Related]
11. Effect of pretreatment with epoxy compounds on the mechanical properties of bovine pericardial bioprosthetic materials.
Xi T; Liu F; Xi B
J Biomater Appl; 1992 Jul; 7(1):61-75. PubMed ID: 1432579
[TBL] [Abstract][Full Text] [Related]
12. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
13. In vitro properties and performance of glutaraldehyde-crosslinked bovine pericardial bioprostheses treated with glutamic acid.
Braile MC; Carnevalli NC; Goissis G; Ramirez VA; Braile DM
Artif Organs; 2011 May; 35(5):497-501. PubMed ID: 21595718
[TBL] [Abstract][Full Text] [Related]
14. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
15. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies.
Vyavahare NR; Jones PL; Hirsch D; Schoen FJ; Levy RJ
J Heart Valve Dis; 2000 Jul; 9(4):561-6. PubMed ID: 10947050
[TBL] [Abstract][Full Text] [Related]
16. Mitigation of calcification and cytotoxicity of a glutaraldehyde-preserved bovine pericardial matrix: improved biocompatibility after extended implantation in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2010 Nov; 19(6):778-85. PubMed ID: 21214104
[TBL] [Abstract][Full Text] [Related]
17. Anticalcification effects of decellularization, solvent, and detoxification treatment for genipin and glutaraldehyde fixation of bovine pericardium.
Lim HG; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Feb; 41(2):383-90. PubMed ID: 21683607
[TBL] [Abstract][Full Text] [Related]
18. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue.
Zilla P; Weissenstein C; Bracher M; Zhang Y; Koen W; Human P; von Oppell U
J Heart Valve Dis; 1997 Sep; 6(5):502-9. PubMed ID: 9330172
[TBL] [Abstract][Full Text] [Related]
19. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
[TBL] [Abstract][Full Text] [Related]
20. Inorganic-polymerization crosslinked tissue-siloxane hybrid as potential biomaterial for bioprosthetic heart valves.
Yang F; He H; Xu L; Jin L; Guo G; Wang Y
J Biomed Mater Res A; 2021 May; 109(5):754-765. PubMed ID: 32681740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
